The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

INSIGHT

Long-term data of BRS presented at EuroPCR 2017 (Friday, 19 May)

EuroIntervention 2017;13:e515-e521 published online e-edition August 2017. DOI: 10.4244/EIJV13I5A82

1. Imperial College London, London, United Kingdom; 2. Cardiology Department, 401 General Military Hospital of Athens, Athens, Greece; 3. Department of Interventional Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, the Netherlands


Abstract

Bioresorbable scaffolds (BRS) were designed more than 30 years ago to overcome the disadvantages related to the permanent implantation of a metallic stent and, at present, a number of these devices have obtained a CE mark on the basis of midterm follow-up studies. However, although BRS have already been introduced into clinical practice, intensive research is ongoing worldwide to clarify their long-term safety and effectiveness. This type of research has captivated the interest of the cardiovascular community after the recent publication of long-term follow-up data from randomised trials demonstrating increased late scaffold thrombosis in the Absorb™ BRS (Abbott ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Optical coherence tomography findings: insights from the “randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions” (PRISON IV) trial